Astera Labs, Inc. $ALAB Shares Sold by Northern Trust Corp

Northern Trust Corp lowered its position in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 1.8% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 290,890 shares of the company’s stock after selling 5,230 shares during the quarter. Northern Trust Corp owned about 0.18% of Astera Labs worth $17,357,000 as of its most recent filing with the SEC.

Several other institutional investors also recently bought and sold shares of ALAB. Hoey Investments Inc. raised its stake in shares of Astera Labs by 4.2% in the 1st quarter. Hoey Investments Inc. now owns 5,000 shares of the company’s stock valued at $298,000 after acquiring an additional 200 shares during the period. Sound Income Strategies LLC lifted its position in Astera Labs by 34.7% during the 1st quarter. Sound Income Strategies LLC now owns 792 shares of the company’s stock worth $47,000 after acquiring an additional 204 shares in the last quarter. Allworth Financial LP grew its position in Astera Labs by 20.4% in the first quarter. Allworth Financial LP now owns 1,394 shares of the company’s stock valued at $90,000 after acquiring an additional 236 shares in the last quarter. GAMMA Investing LLC lifted its position in shares of Astera Labs by 55.7% during the first quarter. GAMMA Investing LLC now owns 794 shares of the company’s stock worth $47,000 after purchasing an additional 284 shares in the last quarter. Finally, Wealthcare Advisory Partners LLC lifted its holdings in Astera Labs by 1.1% in the 1st quarter. Wealthcare Advisory Partners LLC now owns 28,939 shares of the company’s stock worth $1,727,000 after buying an additional 320 shares in the last quarter. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the company. Evercore ISI increased their target price on Astera Labs from $104.00 to $215.00 and gave the company an “outperform” rating in a research note on Wednesday, August 6th. Needham & Company LLC increased their price objective on shares of Astera Labs from $100.00 to $170.00 and gave the company a “buy” rating in a research note on Wednesday, August 6th. CICC Research initiated coverage on shares of Astera Labs in a research report on Friday, August 29th. They issued an “outperform” rating and a $190.00 target price for the company. Wall Street Zen upgraded shares of Astera Labs from a “hold” rating to a “buy” rating in a research note on Saturday, August 16th. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on Astera Labs from $160.00 to $200.00 and gave the stock a “buy” rating in a research note on Tuesday. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $142.00.

Insider Activity

In related news, COO Sanjay Gajendra sold 280,000 shares of the business’s stock in a transaction that occurred on Thursday, August 7th. The stock was sold at an average price of $170.02, for a total transaction of $47,605,600.00. Following the completion of the transaction, the chief operating officer owned 5,525,545 shares in the company, valued at $939,453,160.90. The trade was a 4.82% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Michael Truett Tate sold 100,000 shares of the business’s stock in a transaction on Thursday, August 7th. The shares were sold at an average price of $171.38, for a total transaction of $17,138,000.00. Following the transaction, the chief financial officer directly owned 518,996 shares of the company’s stock, valued at approximately $88,945,534.48. This trade represents a 16.16% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 1,649,489 shares of company stock valued at $232,463,986. 12.50% of the stock is currently owned by insiders.

Astera Labs Stock Performance

Shares of NASDAQ:ALAB opened at $174.24 on Wednesday. The company’s fifty day moving average is $136.10 and its two-hundred day moving average is $96.96. Astera Labs, Inc. has a 1-year low of $36.85 and a 1-year high of $199.47. The stock has a market capitalization of $28.96 billion, a price-to-earnings ratio of 311.14, a price-to-earnings-growth ratio of 4.62 and a beta of 1.48.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, beating the consensus estimate of $0.33 by $0.11. The business had revenue of $191.93 million during the quarter, compared to analyst estimates of $172.46 million. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The company’s quarterly revenue was up 149.5% on a year-over-year basis. During the same period in the previous year, the business posted $0.13 EPS. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Sell-side analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.